SHENZHEN, China, Jan. 18, 2011 /PRNewswire-Asia-FirstCall/ --
Mindray Medical International Limited (NYSE: MR), a leading
developer, manufacturer and marketer of medical devices worldwide,
today announced its participation in the Arab Health 2011, to be
held from January 24-27, 2011 in
Dubai, U.A.E.
Arab Health is the most important annual medical exhibition in
the Middle East. In 2010,
the event had over 2700 exhibitors and around 66,000 visitors from
more than 79 countries. This year, Mindray will exhibit more than
50 devices from its three core product segments: patient monitoring
and life support products, in-vitro diagnostic products and medical
imaging systems. Five important products on exhibit are described
below:
Patient monitoring and life support products:
- the V series Patient Monitoring System
- the WATO-EX 35 Anesthesia Machine
- the BeneHeart D3 Defibrillator
In-Vitro diagnostic products:
- the BS-800 Clinical Chemistry Analyzer
- the BC-6800 Auto Hematology Analyzer
First launched in the US in the fourth quarter of 2010, the V
series platform is a modular patient monitoring system, focusing on
the philosophy of "easy-to-use" while incorporating traditionally
highly complex monitoring parameters. The system is intended for
intra hospital use under the direct supervision of a licensed
healthcare practitioner. The system architecture allows users to
customize, by removal or addition of modules, monitored parameters
based on a patient's monitoring need or acuity level.
First introduced in China, the
WATO EX-35 anesthesia machine is suitable for general anesthesia in
a wide range of patients from infants to adults. With its stable
function, advanced safety design, reliable performance and
user-friendly interface, the WATO gives clinical users basic
monitoring measurements on a color LCD screen, with graphs of
pressure and flow at the same time. In addition to basic
ventilation modes, WATO also offers advanced modes applicable for
patients' spontaneous breathing. The powerful data review supports
24-hour tracking for alarm events. Besides the integrated
monitoring parameters, WATO also provides external monitoring
covering EtCO2 and AG.
BeneHeart D3 defibrillator was first launched in the
international markets. This defibrillator is for hospital
usage and Mindray is currently the only Chinese manufacturer to
have the capability to produce such product. BeneHeart D3 is
a compact, light weight defibrillator integrating manual
defibrillation, monitoring, pacing and AED functions. Quick
charging and shock delivery at customized energy levels ensures
effective resuscitation. This vital signs monitoring function of
ECG, SPO2 and respiration can improve diagnosis efficiency, and
quickly indicates the effective defibrillation.
First launched in China in the
second quarter of 2010, the BS-800 Modular System combines
innovation and high performance into an integrated solution. With
an expandable platform, a more complete line of chemistry reagents,
as well as calibrators and controls, the new solution package can
be tailor-made to customer needs. Innovative features such as
coaxial reagent disk, reagent bubble detection, dot light source
and water quality monitor, are built in to ensure accuracy,
convenience and cost-efficiency.
Mindray will also showcase a demonstration unit of BC-6800, the
new generation 5-part hematology system to be launched this year.
The BC-6800 is a high level auto hematology analyzer with high
processing speed. In addition to the routine CBC plus 5-Part Diff
WBC test, the BC-6800's output can be extended in the form of
Reticulocyte, Nucleated RBC, Optical Platelet count, etc, allowing
wider clinical application and research.
Attending the conference from Mindray will be Mr. Jie Liu, Chief Operating Officer. Mindray will
be hosting booths MB10 and 4F10 at the Dubai International
Convention & Exhibition Centre.
"We are delighted to be attending this important international
event to showcase our latest notable product launches and other
promising products in the pipeline," commented Mr. Jie Liu, Mindray's Chief Operating Officer.
"These products demonstrate that Mindray's focus on research
continues to achieve success, as well as our commitment to deliver
high price-to-performance ratio products to the markets
worldwide."
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in
Mahwah, New Jersey and multiple
sales offices in major international markets. From our main
manufacturing and engineering base in China and through our worldwide distribution
network, we are able to supply internationally a broad range of
products across three primary business segments, comprised of
patient monitoring and life support products, in-vitro diagnostic
products and medical imaging systems. For more information, please
visit http://www.mindray.com.
|
|
For investor and media inquiries
please contact
|
|
|
|
In the U.S.:
|
|
Hoki Luk
|
|
Western Bridge, LLC
|
|
Tel:
+1-646-808-9150
|
|
Email:
hoki.luk@westernbridgegroup.com
|
|
|
|
In China:
|
|
Cathy Gao
|
|
Mindray Medical International
Limited
|
|
Tel:
+86-755-2658-2620
|
|
Email:
cathy.gao@mindray.com
|
|
|
|
|
SOURCE Mindray Medical International Limited